Peter Cegielski

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Tracy Dalton, Peter Cegielski, Somsak Akksilp et al. · The Lancet · 2012 · 227 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study

Aditya Sharma, Andrew Hill, Ekaterina V. Kurbatova et al. · The Lancet Infectious Diseases · 2017 · 153 citations · Full text

Public Health, Health Sciences, Infectious Disease Control +15

Early Results (at 6 Months) with Intermittent Clarithromycin-Including Regimens for Lung Disease Due to Mycobacterium avium Complex

David E. Griffith, B. A. Brown, Peter Cegielski et al. · Clinical Infectious Diseases · 2000 · 118 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Agglutination of Plasmodium falciparum-Infected Erythrocytes from East and West African Isolates by Human Sera from Distant Geographic Regions

J. C. De Aguiar, Peter Cegielski, B. M. Greenwood et al. · American Journal of Tropical Medicine and Hygiene · 1992 · 63 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

In vitro rosetting, cytoadherence, and microagglutination properties of Plasmodium falciparum-infected erythrocytes from Gambian and Tanzanian patients

Thomas Hasler, SM Handunnetti, J C Aguiar et al. · Blood · 1990 · 60 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11